肺癌风险模型个体化定制年度与双年度CT筛查随访
多项式模型准确度0.785,优于患者特征、直径、Patz和PanCan模型。该模型可指导部分参与者安全跳过筛查轮次,但延迟少量肺癌诊断。
要点
- 多项式模型结合患者特征与基线扫描形态,准确度0.785,优于其他模型。
- 使用多项式模型,部分参与者可安全跳过第二轮筛查,但延迟诊断少量肺癌。
- 个体化随访间隔有望减少不必要的筛查轮次,每延迟一例肺癌诊断可使数百人免于筛查。
核心结论
- 多项式模型在分配参与者至1年或2年筛查间隔方面显著优于其他模型。
- 实施个体化随访间隔可使数百名参与者每延迟一例肺癌诊断即跳过一轮筛查。
研究设计与样本
- 研究纳入NLST试验CT臂中2002-2010年接受基线扫描和首次年度随访扫描且第一年未诊断肺癌的参与者。
主要发现
- 多项式模型、患者特征模型、直径模型、Patz模型和PanCan模型的准确度分别为0.785、0.693、0.697、0.666和0.727。
临床怎么用
- 多项式模型可用于个体化定制肺癌CT筛查随访间隔,平衡筛查收益与延迟诊断风险。
- 临床决策时需考虑模型预测的跳过筛查比例及对应的肺癌延迟诊断风险。
局限性
- 研究基于NLST试验CT臂数据,外部适用性需进一步验证。
- 内部验证采用bootstrapping,未进行外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: All lung cancer CT screening trials used fixed follow-up intervals, which may not be optimal. We developed new lung cancer risk models for personalising screening intervals to 1 year or 2 years, and compared these with existing models. METHODS: We included participants in the CT arm of the National Lung Screening Trial (2002-2010) who underwent a baseline scan and a first annual follow-up scan and were not diagnosed with lung cancer in the first year. True and false positives and the area under the curve of each model were calculated. Internal validation was performed using bootstrapping. RESULTS: Data from 24 542 participants were included in the analysis. The accuracy was 0.785, 0.693, 0.697, 0.666 and 0.727 for the polynomial, patient characteristics, diameter, Patz and PanCan models, respectively. Of the 24 542 participants included, 174 (0.71%) were diagnosed with lung cancer between the first and the second annual follow-ups. Using the polynomial model, 2558 (10.4%, 95% CI 10.0% to 10.8%), 7544 (30.7%, 30.2% to 31.3%), 10 947 (44.6%, 44.0% to 45.2%), 16 710 (68.1%, 67.5% to 68.7%) and 20 023 (81.6%, 81.1% to 92.1%) of the 24 368 participants who did not develop lung cancer in the year following the first follow-up screening round could have safely skipped it, at the expense of delayed diagnosis of 0 (0.0%, 0.0% to 2.7%), 8 (4.6%, 2.2% to 9.2%), 17 (9.8%, 6.0% to 15.4%), 44 (25.3%, 19.2% to 32.5%) and 70 (40.2%, 33.0% to 47.9%) of the 174 lung cancers, respectively. CONCLUSIONS: The polynomial model, using both patient characteristics and baseline scan morphology, was significantly superior in assigning participants to 1-year or 2-year screening intervals. Implementing personalised follow-up intervals would enable hundreds of participants to skip a screening round per lung cancer diagnosis delayed.
引用
- Schreuder A, Schaefer-Prokop CM, Scholten ET, et al. Lung cancer risk to personalise annual and biennial follow-up computed tomography screening. Thorax. 2018. PMID: 29602813. doi:10.1136/thoraxjnl-2017-211107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。